Furthermore, a metanalysis showed a positive prognostic role for SDF1/CXCL12 in breast cancer, with its overexpression correlated with better prognosis in terms of both disease-free survival and overall survival of breast cancer [52]. This evidence concerns the gene CXCL12 and breast cancer.